Heron Therapeutics Inc (HRTX)

EBITDA Margin

-13.37%

Quarterly · Period ending:

HRTX logo

HRTX EBITDA Margin

Latest reported-13.37%
HRTX Quarterly EBITDA Margin (100.00% → -13.37%)
High-resolution chart · PNG

HRTX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-13.3728%
-21.8432%
-3.4912%
-36.5844%
-4.7581%
9.4748%
21.4168%
-11.4813%
-22.7459%
-5.5033%
-16.303%
-75.4533%
-130.0926%
-108.2222%
-81.444%
-155.1455%
-201.549%
-269.2885%
-257.5067%
-222.359%
-268.596%
-256.644%
-280.5047%
-288.58%
-242.6504%
-205.1693%
-146.4555%
-80.5462%
-139.9029%
-203.2561%
-149.5112%
-209.2287%
-222.9727%
-446.1745%
-611.8074%
-477.2399%
-489.342%
-1,348.293%
-3,601.3292%
-7,175.4917%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-118.2846%
0%
0%
0%
0%
0%
-595.2191%
-320.7595%
-940.7821%
-450.1425%
-686.6038%
-1,163.4855%
-1,650.8197%
-100.7162%
-27,664.2857%
-35,925%
-17,757.1429%
-9,642.1875%
-4,041.4474%
-5,254.8872%
-5,854.5455%
-4,327.2727%
-2,515.625%
0%
0%
0%
0%
0%
-164.6122%
-137.3972%
-202.24%
-88.3824%
-155.668%
-129.2181%
-182.7103%
-214.4068%
-106.2592%
-85.5678%
-164.9955%
-160.9403%
-14.7533%
-107.0737%
-121.217%
-96.2843%
-133.6326%
-199.4576%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.